New depression drug shows promise in early trial
NCT ID NCT06792136
First seen Jun 27, 2026 · Last updated Jul 09, 2026 · Updated 2 times
Summary
This study tests a new medicine called ONO-1110 in 100 Japanese adults with major depressive disorder. Participants receive either the drug or a placebo for 8 weeks. The main goal is to see if the drug reduces depression symptoms more than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MAJOR DEPRESSIVE DISORDER (MDD) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
AK Clinic
Fukuoka, Japan
-
Harai Clinic
Tokyo, Japan
-
Higashi-Sapporo Mental Clinic
Hokkaido, Japan
-
Hiro Mental Clinic
Fukuoka, Japan
-
Hirota Clinic
Fukuoka, Japan
-
Ichikawa Clinic
Gunma, Japan
-
Iidabashi Mental Clinic
Tokyo, Japan
-
Ikebukuro Olive Mental Clinic
Tokyo, Japan
-
Kawamura Mental Clinic
Hokkaido, Japan
-
Kishiro Mental Clinic
Kanagawa, Japan
-
Kitaikebukuro Kokoro No Clinic
Tokyo, Japan
-
Kokorono Clinic Hirao
Fukuoka, Japan
-
Kokorono Clinic Iizuka
Fukuoka, Japan
-
Kokura Mental Clinic
Fukuoka, Japan
-
Maynds Tower Mental Clinic
Tokyo, Japan
-
Meguroeki Higashiguchi Mental Clinic
Tokyo, Japan
-
Mental Clinic Sakurazaka
Fukuoka, Japan
-
Minami1jo Mental Clinic
Hokkaido, Japan
-
Monzen-nakacho Mental Clinic
Tokyo, Japan
-
Niseikai Murakami Iin
Tokyo, Japan
-
Nishi-Shinjuku Concieria Clinic
Tokyo, Japan
-
Sakurazaka Clinic SophyAnce
Tokyo, Japan
-
Sangenjaya Nakamura Mental Clinic
Tokyo, Japan
-
Sapporo Kobushi Clinic
Hokkaido, Japan
-
Shimode Mental Clinic
Hokkaido, Japan
-
Shinseikai Kaku Mental Clinic
Fukuoka, Japan
-
Tatsuta Clinic
Hyōgo, Japan
-
Uematsu Mental Clinic
Fukuoka, Japan
-
Yutaka Clinic
Kanagawa, Japan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can couples counseling lift depression in women?
- Brain wave clues: could inflammation markers forecast ECT outcomes?
- Can tailored brain zaps beat standard therapy for depression?
- Can a new daily pill lift the fog of depression?
- Can a new pill outsmart depression? a trial puts KH607 to the test
- Depression's biological fingerprint: a quest for objective diagnosis and personalized treatment